Articles, guides, and regulatory updates from our community.
New research explores an engineered inhalable powder combining niclosamide and colistin to combat drug-resistant lung infections in cystic fibrosis patients.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives inflammation and beta-cell death in type 2 diabetes—and what emerging therapies may mean for patients.
By Peptide Association Research Team
New research explores carbonless analogues of the GHK peptide using boron-nitrogen substitution. Learn what this computational study suggests about future peptide design.
By Peptide Association Research Team
New computational research explores carbonless analogues of GHK peptide, suggesting stronger copper binding and broader conformational flexibility. Learn what this means.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 may protect against heart damage from chemotherapy drugs through H2O2 regulation mechanisms.
By Peptide Association Research Team
Groundbreaking 2026 study uncovers how mitochondrial dysfunction drives inflammation and cell death in type 2 diabetes, pointing to new treatment paths.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
Recent research explores mitochondrial-targeted liposomes containing SS-31 peptide for obesity treatment. Study shows improved fat metabolism in animal models.
By Peptide Association Research Team
Recent study reveals how mitochondria-targeted peptide SS-31 could help prevent heart damage from cancer treatment. Learn about this promising research.
By Peptide Association Research Team
New research explores how the mitochondria-targeted antioxidant peptide SS-31 may help protect cardiac function in laboratory studies of doxorubicin toxicity.
By Peptide Association Research Team
New research reveals how repurposing existing drugs could offer faster, safer therapeutic options for Alzheimer's disease treatment and prevention.
By Peptide Association Research Team
Breakthrough study reveals how SS-31 peptide and targeted liposomes may enhance fat burning by improving mitochondrial function in adipose tissue.
By Peptide Association Research Team
New research examines approved vs unapproved peptides for musculoskeletal injuries. Study reveals safety gaps in gray market compounds lacking oversight.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team
New research on carbonless amino acids reveals modified GHK peptides may have stronger metal binding properties. Study findings and clinical implications.
By Peptide Association Research Team
Research reveals how mitochondria-targeted liposomes enhance thermogenesis in fat cells, offering potential obesity treatment through improved cellular metabolism.
By Peptide Association Research Team
Study reveals how spray-drying parameters affect injectable peptide suspension stability through advanced multimodal analysis techniques.
By Peptide Association Research Team
Recent research reveals 81% of newer antidiabetic drugs are cost-effective in developed countries, but accessibility remains limited in developing nations.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team
New research explores repurposing existing drugs for Alzheimer's treatment, highlighting mitochondrial-targeted therapies and multi-target approaches.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team
New nanoencapsulation research reveals enhanced neuroprotection against brain injury. Learn implications for thymosin beta 4 injury treatment approaches.
By Peptide Association Research Team
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New C. elegans study reveals Eleutheroside B's neuroprotective effects through autophagy and antioxidant mechanisms. Learn implications for peptide therapy.
By Peptide Association Research Team
Recent veterinary research on treating dry eye disease offers insights for peptide therapy providers. Find qualified doctors and learn about emerging treatments.
By Peptide Association Research Team
Recent study reveals diammonium glycyrrhizinate and vitamin D3 combination may help treat pulmonary fibrosis through novel mechanisms. Learn about the research.
By Peptide Association Research Team
An honest assessment of BPC-157 research — separating the extensive animal data from the limited human evidence, and what providers should tell patients asking about this popular peptide.
By Peptide Association Editorial Team
How the copper-binding tripeptide GHK-Cu influences wound healing, collagen synthesis, and gene expression — and what the evidence says about its anti-aging potential.
By Peptide Association Editorial Team
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team